Work

Rethinking tuberculosis: Microbiological and immunological crossroads in the post-pandemic era

Year: 2026

Type: article

Abstract: Tuberculosis (TB) remains a major global health concern, further complicated by disruptions in surveillance and management during the COVID-19 pandemic. Emerging evidence positions TB not only as an infectious disease but also as an immune-mediated condition, highlighting the role of host–pathogen interactions in disease persistence. Recent advances in molecular diagnostics, such as metagenomic sequencing, AI-assisted microscopy, and CRISPR-based assays, are transforming early detection and personalized care. At the same time, novel drug regimens for multidrug-resistant TB offer new hope. Integrating host-directed therapies with precision microbiology provides a promising framework for TB control in the post-pandemic era.

Source: Revista Alergia México

DOI: 10.29262/ram.v73i1.1561

Authors: Vijayasimha Mulavagili, Rajesh Prasad Jayaswal

Institution: Chandigarh University

Language: English

Topic: Tuberculosis Research and Epidemiology

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $300